Thomas Hohlfeld

3.1k total citations
97 papers, 2.2k citations indexed

About

Thomas Hohlfeld is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Surgery. According to data from OpenAlex, Thomas Hohlfeld has authored 97 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Cardiology and Cardiovascular Medicine, 35 papers in Pharmacology and 17 papers in Surgery. Recurrent topics in Thomas Hohlfeld's work include Antiplatelet Therapy and Cardiovascular Diseases (53 papers), Inflammatory mediators and NSAID effects (33 papers) and Atrial Fibrillation Management and Outcomes (12 papers). Thomas Hohlfeld is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (53 papers), Inflammatory mediators and NSAID effects (33 papers) and Atrial Fibrillation Management and Outcomes (12 papers). Thomas Hohlfeld collaborates with scholars based in Germany, United Kingdom and Austria. Thomas Hohlfeld's co-authors include Karsten Schrör, E. Gams, Artur‐Aron Weber, Norbert Zimmermann, A.-A. Weber, N. Zimmermann, Amin Polzin, Aaruni Saxena, Jutta Meyer-Kirchrath and Marina Braun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Circulation Research.

In The Last Decade

Thomas Hohlfeld

95 papers receiving 2.1k citations

Peers

Countries citing papers authored by Thomas Hohlfeld

Since Specialization

Citations

This map shows the geographic impact of Thomas Hohlfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hohlfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hohlfeld more than expected).

Fields of papers citing papers by Thomas Hohlfeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Hohlfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hohlfeld. The network helps show where Thomas Hohlfeld may publish in the future.

Co-authorship network of co-authors of Thomas Hohlfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Hohlfeld. A scholar is included among the top collaborators of Thomas Hohlfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Hohlfeld. Thomas Hohlfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel 2022 ·Pharmacology ·René M’Pembele, (unknown), Carolin Helten, Philipp Mourikis, (unknown), (unknown), (unknown), Ragnar Huhn, Tobias Petzold, Thomas Hohlfeld, Tobias Zeus, Malte Kelm, Lisa Dannenberg, Amin Polzin	2
2	Lipid lowering therapy in cardiovascular disease: From myth to molecular reality 2020 ·Pharmacology & Therapeutics ·Philipp Mourikis, (unknown), Lisa Dannenberg, Amir M. Nia, Yvonne Heinen, (unknown), Hannah J. Richter, Thomas Hohlfeld, Tobias Zeus, Malte Kelm, Amin Polzin	44
3	Platelet reactivity in patients with chronic kidney disease and hemodialysis 2019 ·Journal of Thrombosis and Thrombolysis ·Philipp Mourikis, Carolin Helten, Lisa Dannenberg, Thomas Hohlfeld, Johannes Stegbauer, Tobias Petzold, Bodo Levkau, Tobias Zeus, Malte Kelm, Amin Polzin	7
4	Cyclooxygenase activity in bradykinin-induced dermal extravasation. A study in mice and humans 2019 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), Janina Hahn, Ulrich Straßen, (unknown), (unknown), Thomas K. Hoffmann, Thomas Hohlfeld, Jens Greve, Murat Baş, Sören Twarock, Georg Kojda	6
5	Thromboxane Formation Assay to Identify High On-Treatment Platelet Reactivity to Aspirin 2017 ·Pharmacology ·(unknown), Kerstin Piayda, Lisa Dannenberg, (unknown), Theresa Schneider, (unknown), Bodo Levkau, Tobias Zeus, Malte Kelm, Thomas Hohlfeld, Amin Polzin	6
6	Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study 2011 ·European Archives of Psychiatry and Clinical Neuroscience ·Joachim Cordes, Kai G. Kahl, Christian Werner, U. Henning, (unknown), Rolf Larisch, Christian Schmidt-Kraepelin, (unknown), M.W. Agelink, (unknown), Thomas Hohlfeld, Wolfgang Gäebel, A. Klimke	4
7	Abstract 16950: Sphingosine-1-Phosphate is Thromboxane-dependently Released from Platelets and Modulates Chemotaxis of Human Monocytes 2010 ·Circulation ·Amin Polzin, Andreas Böhm, (unknown), A Rosenkranz, Thomas Hohlfeld, Karsten Schrör, Bernhard H. Rauch	1
8	Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with 99mTc- and 123I-labelled probes 2009 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Jutta Meyer-Kirchrath, Thomas Hohlfeld, S. Vollmar, Ana‐Maria Oros‐Peusquens, Ulrich Flögel, Christoph Jacoby, Ute Krügel, N. Schramm	8
9	Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent 2008 ·European Journal of Cardio-Thoracic Surgery ·Norbert Zimmermann, E. Gams, Thomas Hohlfeld	60
10	Aspirin-induced platelet inhibition in patients undergoing cardiac surgery 2007 ·Platelets ·Norbert Zimmermann, Muhammed Kurt, Joachim Winter, E. Gams, Folker Wenzel, (unknown), Thomas Hohlfeld	15
11	Abstract 480: Platelet Activation After Cardiac Surgery Increases Thrombogenicity After Valve Replacement and Contributes to "Aspirin-Resistance" After Coronary Artery Bypass Grafting 2006 ·Circulation ·Norbert Zimmermann, Muhammed Kurt, Folker Wenzel, Joachim Winter, E. Gams, Thomas Hohlfeld	1
12	DELAYED PRECONDITIONING VIA ANGIOTENSIN‐CONVERTING ENZYME INHIBITION: PROS AND CONS FROM AN EXPERIMENTAL STUDY 2006 ·Clinical and Experimental Pharmacology and Physiology ·(unknown), (unknown), P. Feindt, Thomas Hohlfeld, Jochen D. Schipke, E. Gams	6
13	Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man 2003 ·Behavioural Brain Research ·Rolf Larisch, A. Klimke, Kurt Hamacher, U. Henning, (unknown), Thomas Hohlfeld, H. Vosberg, Marco Tosch, Wolfgang Gäebel, Heinz H. Coenen, (unknown)	23
14	Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers 2001 ·British Journal of Clinical Pharmacology ·Artur‐Aron Weber, Marina Braun, Thomas Hohlfeld, B. Schwippert, Diethelm Tschöpe, Karsten Schrör	132
15	Reduction of Infarct Size by Selective Stimulation of Prostaglandin EP3Receptors in the Reperfused Ischemic Pig Heart 2000 ·Journal of Molecular and Cellular Cardiology ·Thomas Hohlfeld, Jutta Meyer-Kirchrath, (unknown), Karsten Schrör	40
16	40 mg of Aspirin Are Not Sufficient to Inhibit Platelet Function under Conditions of Limited Compliance 2000 ·Thrombosis Research ·Artur-Aron Weber, (unknown), Thomas Hohlfeld, (unknown)	8
17	Acetylsalicylic acid enhances arrhythmogeneity in a model of local ischemia of isolated rabbit hearts 1997 ·European Journal of Pharmacology ·Stefan Dhein, (unknown), Eric Gottwald, Thomas Hohlfeld, Aida Salameh, Wolfgang Klaus	3
18	Antiatherosclerotic effects of oral cicaprost in experimental hypercholesterolemia in rabbits 1993 ·Atherosclerosis ·Marina Braun, Thomas Hohlfeld, Peter Kienbaum, Artur-Aron Weber, Mario Sarbia, (unknown)	14
19	The actions of lovastatin on platelet function and platelet eicosanoid receptors in type II hypercholesterolaemia 1993 ·European Journal of Clinical Pharmacology ·(unknown), Thomas Hohlfeld, G. Wambach, (unknown)	17
20	Oral Cicaprost Protects from Hypercholesterolaemia-Induced Impairment of Coronary Vasodilation 1992 ·Birkhäuser Basel eBooks ·(unknown), Thomas Hohlfeld, H. Strobach, Karsten Schrör	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact